TY - GEN
T1 - Low-dose glucocorticoid therapy in rheumatoid arthritis
T2 - An obligatory therapy: Annals of the New York Academy of Sciences
AU - Bijlsma, Johannes W J
AU - Van Der Goes, Marlies C.
AU - Hoes, Jos N.
AU - Jacobs, Johannes W G
AU - Buttgereit, Frank
AU - Kirwan, John
PY - 2010/4/1
Y1 - 2010/4/1
N2 - Glucocorticoids (GCs) are used extensively in patients with rheumatoid arthritis (RA). Recent data on the efficacy of these drugs in alleviating symptoms of inflammation, but also in retarding erosive damage, are presented. In addition, a critical review of the rather limited literature on adverse effects of chronic use of low dose GCs is given. It becomes clear that the net effect of low-dose GCs in the treatment of rheumatoid arthritis favors the beneficial aspects of these drugs above the negative aspects. Prudent use of GCs can be recommended.
AB - Glucocorticoids (GCs) are used extensively in patients with rheumatoid arthritis (RA). Recent data on the efficacy of these drugs in alleviating symptoms of inflammation, but also in retarding erosive damage, are presented. In addition, a critical review of the rather limited literature on adverse effects of chronic use of low dose GCs is given. It becomes clear that the net effect of low-dose GCs in the treatment of rheumatoid arthritis favors the beneficial aspects of these drugs above the negative aspects. Prudent use of GCs can be recommended.
KW - DMARDs
KW - EULAR guidelines
KW - Glucocorticoids
KW - Rheumatoid arthritis
UR - http://www.scopus.com/inward/record.url?scp=77951225651&partnerID=8YFLogxK
U2 - 10.1111/j.1749-6632.2009.05342.x
DO - 10.1111/j.1749-6632.2009.05342.x
M3 - Conference Contribution (Conference Proceeding)
C2 - 20398017
AN - SCOPUS:77951225651
SN - 9781573317696
VL - 1193
T3 - Annals of the New York Academy of Sciences
SP - 123
EP - 126
BT - Annals of the New York Academy of Sciences
ER -